Primary Health Properties PLC

Director's Dealing • Sep 8, 2025

National Storage Mechanism | Additional information

RNS Number : 4550Y

Primary Health Properties PLC

08 September 2025

Primary Health Properties PLC

Director's & PDMR Dealings - LTIP Vesting

Primary Health Properties PLC (the "Company" or "PHP"), one of the UK's leading investors in modern primary healthcare facilities, announces that Richard Howell, Chief Financial Officer, together with a further person discharging managerial responsibility ("PDMR"), have received Ordinary Shares of 12.5 pence each in the Company ("Ordinary Shares") under the terms of the Company's Long-Term Incentive Plan ("LTIP") (the "Vesting").  

Following conclusion of the recent extended closed period, the awards vested on 8 September 2025 for nil consideration pursuant to a conditional award made on 21 February 2022.  For both Mr Howell and Mr Austin, the number of Ordinary Shares which vested is stated after the deduction of the relevant taxation and National Insurance charges.

Director	Number of shares vesting
Richard Howell	101,556
PDMR
David Austin	23,552

All Ordinary Shares in connection with the Vesting will be transferred to the relevant individuals from the Company's employee benefit trust ("EBT").

Details of the operation of the LTIP are set out in the Company's 2024 Report and Accounts.

Details of the transactions referenced above are included below in accordance with Article 19 of the retained EU law version of the Market Abuse Regulation (Regulation 596/2014).

1	Details of the person discharging managerial responsibilities/persons closely associated
(a)	Name	Richard Howell
2	Reason for notification
(a)	Position/Status	Chief Financial Officer
(b)	Initial notification/amendment	Initial notification
3	Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor
(a)	Name	Primary Health Properties PLC
(b)	LEI	213800Y5CJHXOATK7X11
4	Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date: and (iv) each place where transactions have been conducted
(a)	Description of the financial instrument, type of instrument and identification code	Ordinary shares of 12.5p ISIN: GB00BYRJ5J14
(b)	Nature of transaction	Vesting of conditional share awards under the Company's LTIP
(c)	Price(s) and volume(s)	Price(s)	Volume(s)
Nil cost	101,556
(d)	Aggregated Information	Single transaction: N/A
(e)	Date of transaction	8 September 2025
(f)	Place of transaction	London Stock Exchange (XLON)

1	Details of the person discharging managerial responsibilities/person closely associated
(a)	Name	David Austin
2	Reason for notification
(a)	Position/Status	PDMR
(b)	Initial notification/amendment	Initial notification
3	Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor
(a)	Name	Primary Health Properties PLC
(b)	LEI	213800Y5CJHXOATK7X11
4	Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date: and (iv) each place where transactions have been conducted
(a)	Description of the financial instrument, type of instrument and identification code	Ordinary shares of 12.5p ISIN: GB00BYRJ5J14
(b)	Nature of transaction	Vesting of conditional share awards under the Company's LTIP
(c)	Price(s) and volume(s)	Price(s)	Volume(s)
Nil cost	23,552
(d)	Aggregated Information	Single transaction: N/A
(e)	Date of transaction	8 September 2025
(f)	Place of transaction	London Stock Exchange (XLON)

More information on Primary Health Properties PLC can be found on www.phpgroup.co.uk

Further details for enquiries:

Mark Davies Chief Executive Officer	via Burson Buchanan Tel: +44 (0) 20 7466 5066
Richard Howell Chief Financial Officer	via Burson Buchanan Tel: +44 (0) 20 7466 5066
Stephanie Whitmore (Burson Buchanan) Tel: +44 (0) 20 7466 5066

Legal Entity Identifier: 213800Y5CJHXOATK7X11

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact [email protected] or visit www.rns.com.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.

END

DSHBXGDCBXGDGUI